-
News | 2022.06.07
Small/medium-sized companies in the healthcare sector: see you at Pasteur Innov’ Day!
Are you a small or medium-sized company in the healthcare sector and are you looking for a collaborator of choice to overcome a scientific or technological barrier? Register for Pasteur Innov' Day on July 7, 2022, and come and discover some of our iconic innovations. The Pasteur Innov’ day is an opportunity to meet our scientific experts and business managers to discuss your innovation projects...
-
Document de presse | 2022.06.07
Institut Pasteur and MSDAVENIR sign a partnership to improve strategies for controlling the spread of vector-borne viral diseases like Zika
The Institut Pasteur and MSDAVENIR, a health research endowment fund by MSD, signed an important partnership to anticipate responses to future vector-borne viral epidemics today. The partnership, worth more than €1.7 million, will support the INTRANZIGEANT project led by Dr. Louis Lambrechts, head of the Virus-Insect Interactions Unit, and Xavier Montagutelli, head of the Mouse Genetics...
-
News | 2022.06.08
The role of social sciences in the response to an epidemic: the example of the COVID-19 pandemic
A lesser known but equally crucial dimension in managing and responding to an epidemic is social sciences in health, which can shed light on populations' understanding, perception and acceptance of the risks associated with diseases. The COVID-19 pandemic is no exception. As the disease spread across the planet, clear differences in perception by populations were observed in different countries,...
-
News | 2021.12.09
research, education, and economic development: first assessment of 3ia network actions
At the intersection of public and private research, the 3IA institutes create the ideal conditions for collaboration between world-class academic researchers and key drivers of innovation (start-ups, SMEs, or large corporations) and thereby strengthen the economic vitality of their environment. Although they each have their unique features, the 3IA insitutes also work in a network. Since...
-
News | 2021.09.21
Launch of the Medtech Generator & Accelerator program
The support project Medtech Generator & Accelerator (MGA), selected as a winning project in the second SIA call for proposals under the French government's Investing in the Future scheme (operated by Bpifrance), began in September 2021. Developed jointly by the Brain and Spine Institute, the Institut Imagine, the Institut Pasteur and the Institut de la Vision, the program aims to...
-
News | 2021.09.07
The Institut Pasteur attends the Cap’Carnot event on September 28, 2021
Cap'Carnot is the annual summer event organized by the Association of Carnot Institutes to promote dialog between the Carnot Institutes and drivers of innovation. For its second edition, Cap'Carnot will be held on Tuesday September 28, 2021 from 5 to 8pm at NEWCAP in Paris’ 15th arrondissement, and will be an opportunity to celebrate 15 years of R&D initiatives by Carnot...
-
News | 2021.03.04
Pfbioassays
The Institut Pasteur will be setting up the project Pfbioassays (in French) funded by the French government and the Greater Paris Region, on its campus (Thierry Rose and Sébastien Quesney). The aim of the project is to develop a highly automated technological bioassay system involving the packaging and analysis of serum samples. This new system, based on state-of-the-art...
-
News | 2022.06.14
A New Drug Target against Malaria
Malaria is a disease that continues to cause tremendous suffering and mortality in the tropics. This disease is caused by Plasmodium parasites. The species Plasmodium falciparum causes the severest and most deadly form of malaria. Scientists from Institut Pasteur studied the blood stage of the parasites and found a mechanism which could lead to new and efficient drugs against Malaria.Despite...
-
Document de presse | 2022.06.15
COVID-19: Identification of broadly SARS-CoV-2 neutralizing monoclonal antibodies
Although the different SARS-CoV-2 variants currently in circulation are undoubtedly less severe in vaccinated individuals in the general population, immunocompromised people are at greater risk of developing severe forms of COVID-19. Monoclonal antibodies currently offer the best approach, both as a preventive and curative treatment for these patients. Scientists from the Institut Pasteur and...
-
Article | 2022.06.20
4-year Research Group in entomology within Centre Pasteur Cameroun
To reinforce the research on arbovirus transmission at the Centre Pasteur du Cameroun (CPC), the Institut Pasteur will support the creation of a 4-year Research Group (G4) with a focus on entomology in this institute.
